Bright Path

Gratis

1.0for iPhone

SpursTech, LLC

Developer

25/06/2020

Update Date

Education

Category

App Store

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

لقطات الشاشة لـ Bright Path

iPhone

About Bright Path

Bright Path is a mobile health research tool designed to offer additional support to teens and adolescents in therapy and/or counseling for mental health and substance use concerns. The app includes information and activities about coping, mental health, substance use, communication, and healthy decision making. Access to online resources with further information about emotional and behavioral health is also available.

Development and evaluation of the Bright Path web-based mobile application is designed to target co-occurring problems, tailor content to patients’ specific needs, enhance patient treatment engagement, and contribute to lasting improvements in teens’ mental health.

Research Team: Pediatric Behavioral Health Development and Technology Research Lab

Director: Dr. Zachary Adams, Ph.D., HSPP

Funding: The app development and research is supported by the K23 Mentored Patient-Oriented Research Career Development Award (NIH/NIDA K23DA038257)

Partners: Indiana University School of Medicine (IUSOM) and HIT